Eighth, though we found strong and suggestive evidence for associations of genetically proxied PPARG perturbation with ER+ breast cancer and prostate cancer risk, respectively, after applying a Bonferroni correction to account for multiple testing, we cannot rule out the possibility that these findings represent false-positive results. This evidence concerns the gene PPARG and prostate carcinoma.